eIF6 as a Promising Diagnostic and Prognostic Biomarker for Poorer Survival of Cutaneous Melanoma

Overview of attention for article published in Frontiers in oncology, May 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 7 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 9,287 followers.

New article: eIF6 as a Promising Diagnostic and Prognostic Biomarker for Poorer Survival of Cutaneous Melanoma https://t.co/DDJoCLR56S #melanoma #oncology https://t.co/VWJzwe8zqG

16 Jun 2022

Reply Repost Favourite

RT @DermalCell: In @FrontOncology! Researchers 🔎 revealed that eIF6 was highly over-expressed in #melanomas compared to normal skin speci…

31 May 2022

Reply Repost Favourite

In @FrontOncology! Researchers 🔎 revealed that eIF6 was highly over-expressed in #melanomas compared to normal skin specimens, and thus the abnormally high level of eIF6 can be a diagnostic marker for melanoma. Access the full article here! ➡️ https:/

30 May 2022

Reply Repost Favourite

New research: eIF6 as a Promising Diagnostic and Prognostic Biomarker for Poorer Survival of Cutaneous Melanoma: Background Skin cutaneous melanoma (SKCM) is the deadliest skin cancer and has the most rapidly increasing incidences among all… https://t.co/

30 May 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.